# Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting

> **NCT00503386** · PHASE2 · COMPLETED · sponsor: **Hangzhou Jiuyuan Gene Engineering Co. Ltd.,** · enrollment: 144 (actual)

## Conditions studied

- Nausea
- Vomiting
- Chemotherapy

## Interventions

- **DRUG:** Palonosetron
- **DRUG:** Granisetron

## Key facts

- **NCT ID:** NCT00503386
- **Lead sponsor:** Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2010-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503386, "Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00503386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*